Total study duration up to 74 weeks: screening up to 4 weeks, AID assessment phase 12 weeks, extension phase 52 weeks, post-treatment follow-up of 6 weeks.

For patients not entering the extension phase, total study duration up to 22 weeks (screening, AID assessment phase and follow-up).

Read more: http://www.clinicaltrials.gov/ct2/show/NCT02057250?cond=%22Arthritis%22&lup_s=01/29/2014&lup_d=30